Pharmacokinetics of Glepaglutide, A Long-Acting Glucagon-Like Peptide-2 Analogue: A Study in Healthy Subjects
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1918
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pharmacokinetics of Glepaglutide, A Long-Acting Glucagon-Like Peptide-2 Analogue: A Study in Healthy Subjects ; volume:42 ; number:12 ; day:2 ; month:11 ; year:2022 ; pages:1093-1100 ; date:12.2022
Clinical drug investigation ; 42, Heft 12 (2.11.2022), 1093-1100, 12.2022
- Creator
-
Agersnap, Mikkel Askjær
Sonne, Kim
Knudsen, Kim Mark
Knudsen, Carsten Boye
Berner-Hansen, Mark
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40261-022-01210-1
- URN
-
urn:nbn:de:101:1-2023020921000951660005
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Agersnap, Mikkel Askjær
- Sonne, Kim
- Knudsen, Kim Mark
- Knudsen, Carsten Boye
- Berner-Hansen, Mark
- SpringerLink (Online service)
Other Objects (12)
Long-Acting Glucagon-Like Peptide-1 Receptor Agonist-Induced Rheumatoid Arthritis in a Patient with Type 2 Diabetes Mellitus
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Effects of the long-acting glucagon-like peptide-1 receptor agonist liraglutide in adolescent pigs with impaired glucose-dependent insulinotropic polypeptide receptor function
Effects of the long-acting glucagon-like peptide-1 receptor agonist liraglutide in adolescent pigs with impaired glucose-dependent insulinotropic polypeptide receptor function
Long-Acting Reversible Contraception
Glucagon-like peptide 1 (GLP-1)
Glucagon-like peptide-1 7-36 amid
Subpopulation Differences in the Cardiovascular Efficacy of Long-Acting Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short- and long-acting glucagon-like peptide-1 receptor agonists in type 2 diabetes
Long-acting CCK analogue NN9056 lowers food intake and body weight in obese Göttingen Minipigs
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Long-Acting Glucagon-Like Peptide-1 Receptor Agonist-Induced Rheumatoid Arthritis in a Patient with Type 2 Diabetes Mellitus
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Effects of the long-acting glucagon-like peptide-1 receptor agonist liraglutide in adolescent pigs with impaired glucose-dependent insulinotropic polypeptide receptor function
Effects of the long-acting glucagon-like peptide-1 receptor agonist liraglutide in adolescent pigs with impaired glucose-dependent insulinotropic polypeptide receptor function
Long-Acting Reversible Contraception
Glucagon-like peptide 1 (GLP-1)
Glucagon-like peptide-1 7-36 amid
Subpopulation Differences in the Cardiovascular Efficacy of Long-Acting Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short- and long-acting glucagon-like peptide-1 receptor agonists in type 2 diabetes
Long-acting CCK analogue NN9056 lowers food intake and body weight in obese Göttingen Minipigs
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Long-Acting Glucagon-Like Peptide-1 Receptor Agonist-Induced Rheumatoid Arthritis in a Patient with Type 2 Diabetes Mellitus
Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration
Effects of the long-acting glucagon-like peptide-1 receptor agonist liraglutide in adolescent pigs with impaired glucose-dependent insulinotropic polypeptide receptor function
Effects of the long-acting glucagon-like peptide-1 receptor agonist liraglutide in adolescent pigs with impaired glucose-dependent insulinotropic polypeptide receptor function
Long-Acting Reversible Contraception
Glucagon-like peptide 1 (GLP-1)
Glucagon-like peptide-1 7-36 amid
Subpopulation Differences in the Cardiovascular Efficacy of Long-Acting Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
Macronutrient intake, appetite, food preferences and exocrine pancreas function after treatment with short- and long-acting glucagon-like peptide-1 receptor agonists in type 2 diabetes
Long-acting CCK analogue NN9056 lowers food intake and body weight in obese Göttingen Minipigs
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison